There are new available articles, click to refresh the page.

Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’

By: Melissa Rudy — June 11^th 2024 at 17:38

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel on Monday. Industry experts and doctors shared reactions.